Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Researchers Rebecca Kehm, PhD and Lauren Houghton, PhD, shed light on an emerging trend in early onset breast cancer, pointing to early adolescence as a key window that could provide needed answers.
A new advisory on how alcohol increases cancer risk addresses the growing body of evidence about alcohol’s harmful health impacts, including its direct link to cancer.
Using a clever combination of new computer algorithms and cell culture techniques, scientists at the HICCC have addressed a question that’s long troubled cancer researchers.
In this edition of Notes from the Lab, scientists at the Irving Institute for Cancer Dynamics showcase their mathematical framework for studying cancer cell evolution.
A team of Columbia physician-scientists have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier to better treat pediatric brain tumors.
New research by the labs of Nicholas Arpaia, PhD, (pictured) and Tal Danino, PhD, marks a major step forward in efforts to enlist non-pathogenic bacteria to combat cancer.
Meet HICCC member Yvon Woappi, PhD, whose childhood fascination with science and inspiration taken from his late father, also a scientist, helped shape his career trajectory today.
A new study by Elham Azizi and Ben Izar shows a new technique to study cancer tissues archived in biobanks, increasing the variety of samples for analysis and the discovery of biomarkers.
A novel combination immunotherapy shows promise in treating an aggressive type of B-cell lymphoma, according to new research presented by Dr. Jennifer Amengual and team at the ASH Annual Meeting